Company news
Universal Ibogaine Inc news in 2025
Universal Ibogaine Inc's news releases, calls and decks from 2025, newest first.
Universal Ibogaine Provides Bi-weekly Default Status Report on 2025 Year-end Filings and Update on Restructuring Process
December 18, 2025
Universal Ibogaine advises further on application for Management Cease Trade Order
December 2, 2025
Universal Ibogaine Advises of Filing Application for Management Cease Trade Order
November 25, 2025
Universal Ibogaine Provides Corporate Update
October 28, 2025
Universal Ibogaine Announces Board Changes
September 23, 2025
Universal Ibogaine Announces Results of the Annual Meeting of Shareholders
September 14, 2025
Universal Ibogaine Inc. provides update on intent to file Clinical Trial Application with Health Canada and confirms securing of Ibogaine drug supply
September 4, 2025
Universal Ibogaine advises of appointment of two new Board Members
September 3, 2025
Universal Ibogaine advises of departure of CFO
July 16, 2025
Universal Ibogaine Advises of Debt Settlement with CEO and Resignation of a Member of its Board of Directors
July 7, 2025
Universal Ibogaine Advises of Debt Settlement Agreement and Update on Status of Cease Trade Order
April 3, 2025
Universal Ibogaine Provides Update on Status of Current Cease Trade Order
February 5, 2025
Universal Ibogaine provides Bi-weekly Default Status Report on year-end filings
January 27, 2025
Universal Ibogaine Announces Closing of Sale of Belize Property
January 22, 2025
Universal Ibogaine Provides Bi-weekly Status Report on Year-end Filings and update on Belize Property Sale
January 13, 2025
Decks in 2025
- Investor Presentation (July 2025)
Investor deck · 25 slides · Jul 23, 2025
- Investor Presentation (March 2025)
Investor deck · 25 slides · Mar 25, 2025